Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquale Mone

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
Aging Clinical and Experimental Research|June 8, 2021
Cognitive dysfunction correlates with physical impairment in frail patients with acute myocardial infarctionPasquale Mone, Jessica Gambardella, Antonella Pansini, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2022
Epidemiology of obstructive sleep apnea: What is the contribution of hypertension and arterial stiffness?Pasquale Mone, Urna Kansakar, Fahimeh Varzideh, et al.
Aging Clinical and Experimental Research|April 5, 2021
Impact of thrombus aspiration in frail STEMI patientsPasquale Mone, Jessica Gambardella, Antonella Pansini, et al.
International Journal of Molecular Sciences|February 13, 2025
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic PotentialCheryl Tung, Fahimeh Varzideh, Emanuele Farroni, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2022
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic PatientsPasquale Mone, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
Atherosclerosis|November 17, 2025
Unmasking the genetic double agents of hyperglycemia: Mendelian randomization in endotheli-hell espionageShivangi Pande, Fahimeh Varzideh, George Ishak, et al.
The Lancet. Healthy Longevity|September 16, 2024
SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?Pasquale Mone, Michele Ciccarelli, Stanislovas S Jankauskas, et al.
Atherosclerosis|October 22, 2024
Age drives the impact of vascular disease on ischemic stroke in patients with atrial fibrillation: Role of hypertension and prediabetesPasquale Mone, Florindo D'Onofrio, Tommaso Dazzetti, et al.
Military Medical Research|January 3, 2024
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathyStanislovas S Jankauskas, Fahimeh Varzideh, Pasquale Mone, et al.
Frontiers in Aging|August 4, 2022
Functional role of miR-34a in diabetes and frailtyPasquale Mone, Antonio de Donato, Fahimeh Varzideh, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
Aging Clinical and Experimental Research|June 8, 2021
Cognitive dysfunction correlates with physical impairment in frail patients with acute myocardial infarctionPasquale Mone, Jessica Gambardella, Antonella Pansini, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 14, 2022
Epidemiology of obstructive sleep apnea: What is the contribution of hypertension and arterial stiffness?Pasquale Mone, Urna Kansakar, Fahimeh Varzideh, et al.
Aging Clinical and Experimental Research|April 5, 2021
Impact of thrombus aspiration in frail STEMI patientsPasquale Mone, Jessica Gambardella, Antonella Pansini, et al.
International Journal of Molecular Sciences|February 13, 2025
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic PotentialCheryl Tung, Fahimeh Varzideh, Emanuele Farroni, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2022
SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic PatientsPasquale Mone, Fahimeh Varzideh, Stanislovas S Jankauskas, et al.
Atherosclerosis|November 17, 2025
Unmasking the genetic double agents of hyperglycemia: Mendelian randomization in endotheli-hell espionageShivangi Pande, Fahimeh Varzideh, George Ishak, et al.
The Lancet. Healthy Longevity|September 16, 2024
SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?Pasquale Mone, Michele Ciccarelli, Stanislovas S Jankauskas, et al.
Atherosclerosis|October 22, 2024
Age drives the impact of vascular disease on ischemic stroke in patients with atrial fibrillation: Role of hypertension and prediabetesPasquale Mone, Florindo D'Onofrio, Tommaso Dazzetti, et al.
Military Medical Research|January 3, 2024
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathyStanislovas S Jankauskas, Fahimeh Varzideh, Pasquale Mone, et al.
Frontiers in Aging|August 4, 2022
Functional role of miR-34a in diabetes and frailtyPasquale Mone, Antonio de Donato, Fahimeh Varzideh, et al.
Pageof 14